27/05/2024
African Healthcare and Drug Association in cooperation with the Egyptian Foundation for Pharmaceutical Research are pleased to announce their successful collaboration to raise the awareness of the importance of Clinical Research in Egypt 🇪🇬 as a great potential to provide healthcare added values to the Africans.
Clinical research improves access to healthcare, strengthens regulatory frameworks, and promotes data sharing.
Our primary objective is to highlight Egypt's considerable capacity for clinical research and cultivate an environment conducive to research investments. This entails ensuring that the opportunity size aligns proportionately with the number of studies conducted, optimizing the balance for maximum impact. To achieve this, we aim to actively address key hindrances that currently impede clinical research progress in Egypt. Through the implementation of comprehensive improvements and strategic reforms in the clinical research landscape, our overarching goal is to foster an atmosphere that attracts substantial growth in the number of clinical trials. By systematically optimizing these crucial factors, we aspire to position Egypt as a thriving and innovative hub for impactful clinical research initiatives.
Regulate and promote the adoption of real-world data concepts to take advantage of a wider array of valuable healthcare insights. Simultaneously, establish robust registries to collect and utilize this data effectively, by that, we can develop an inclusive health map to streamline patient identification and engagement, and thus, enhancing the efficiency of clinical trial recruitment, furthermore develop comprehensive databases dedicated to cataloging and organizing clinical trial information, enhancing accessibility, and efficiency in research endeavors.
